NASDAQ : AKTX
Akari Therapeutics, Plc — Financial statements
Healthcare · Biotechnology · United States
Last price 8.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 18.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 8.81M | 9.28M | 9.66M | 11.36M | 13.53M | 8.08M |
| Research & Development | 4.87M | 2.81M | 6.98M | 5.45M | 9.56M | 9.13M |
| Operating Expenses | 13.68M | 12.10M | 16.65M | 16.81M | 23.09M | 17.21M |
| Operating Income | -13.68M | -12.10M | -16.65M | -16.81M | -23.09M | -17.21M |
| Interest Expense | -985.00K | -949.00K | -244.00K | |||
| Interest & Investment Income | 1.00K | 1.00K | 8.00K | 82.00K | 46.00K | 10.60K |
| Currency Exchange Gain (Loss) | -230.00K | -443.00K | 6.00K | 136.00K | 453.00K | -193.22K |
| Other Non Operating Income (Expenses) | 3.62M | 3.53M | 2.08M | 6.58M | 4.84M | -27.48K |
| EBT Excluding Unusual Items | -11.27M | -9.96M | -14.79M | -10.01M | -17.75M | -17.42M |
| Merger & Restructuring Charges | -5.00M | |||||
| Impairment of Goodwill | -8.43M | |||||
| Asset Writedown | -8.88M | -5.18M | ||||
| Other Unusual Items | -4.24M | -3.16M | ||||
| Pretax Income | -32.82M | -18.30M | -19.79M | -10.01M | -17.75M | -17.42M |
| Income Tax Expense | -1.86M | -1.00M | ||||
| Net Income | -30.96M | -17.30M | -19.79M | -10.01M | -17.75M | -17.42M |
| Net Income to Common | -30.96M | -17.30M | -19.79M | -10.01M | -17.75M | -17.42M |
| Shares Outstanding (Basic) | 1.29M | 841.60K | 298.60K | 122.36K | 78.04K | 53.65K |
| Shares Outstanding (Diluted) | 1.29M | 841.60K | 298.60K | 122.36K | 78.04K | 53.65K |
| EPS (Basic) | -23.94 | -20.55 | -66.28 | -81.79 | -227.41 | -324.77 |
| EPS (Diluted) | -23.94 | -20.55 | -66.28 | -81.79 | -227.41 | -324.77 |
| Free Cash Flow | -10.76M | -10.57M | -12.55M | -16.43M | -21.50M | -18.85M |
| Free Cash Flow Per Share | -8.32 | -12.56 | -42.04 | -134.29 | -275.54 | -351.28 |
| EBITDA | -12.08M | -16.63M | -16.80M | -23.08M | -17.21M | |
| D&A For EBITDA | 14.00K | 14.00K | 4.00K | 4.00K | 4.13K | |
| EBIT | -13.68M | -12.10M | -16.65M | -16.81M | -23.09M | -17.21M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 7.69M | 5.20M | 2.60M | 3.85M | 13.25M | 9.36M |
| Cash & Short-Term Investments | 7.69M | 5.20M | 2.60M | 3.85M | 13.25M | 9.36M |
| Prepaid Expenses | 532.00K | 185.00K | 92.00K | 299.00K | 465.00K | 2.17M |
| Restricted Cash | 60.00K | 60.00K | 60.00K | |||
| Other Current Assets | 38.00K | 14.00K | 201.00K | 197.00K | 100.00K | 90.30K |
| Total Current Assets | 8.32M | 5.46M | 2.95M | 4.34M | 13.81M | 11.63M |
| Goodwill | 8.43M | 8.43M | ||||
| Other Intangible Assets | 30.30M | 34.00M | 39.18M | 14.00K | 17.00K | 22.93K |
| Total Assets | 38.62M | 47.89M | 50.56M | 4.36M | 13.83M | 11.65M |
| Accounts Payable | 9.40M | 8.77M | 12.41M | 1.67M | 947.00K | 1.79M |
| Accrued Expenses | 3.51M | 2.34M | 3.14M | 1.57M | 3.15M | 3.18M |
| Short-Term Debt | 693.00K | 754.00K | 3.26M | |||
| Other Current Liabilities | 328.00K | 485.00K | 1.11M | 1.35M | 7.95M | 1.12M |
| Total Current Liabilities | 13.94M | 12.35M | 19.91M | 4.58M | 12.04M | 6.09M |
| Long-Term Deferred Tax Liabilities | 6.09M | 6.95M | 8.04M | |||
| Other Long-Term Liabilities | 261.00K | 383.00K | ||||
| Total Liabilities | 20.03M | 19.56M | 28.33M | 4.58M | 12.04M | 6.09M |
| Common Stock | 1.00K | 5.32M | 1.32M | 745.00K | 475.97K | |
| Additional Paid-In Capital | 243.76M | 234.32M | 212.71M | 174.75M | 167.08M | 153.13M |
| Retained Earnings | -283.81M | -264.55M | -247.25M | -227.46M | -217.45M | -199.71M |
| Comprehensive Income & Other | 58.65M | 58.56M | 51.46M | 51.15M | 51.42M | 51.65M |
| Shareholders' Equity | 18.59M | 28.33M | 22.23M | -229.00K | 1.79M | 5.55M |
| Total Liabilities & Equity | 38.62M | 47.89M | 50.56M | 4.36M | 13.83M | 11.65M |
| Total Debt | 693.00K | 754.00K | 3.26M | |||
| Net Cash (Debt) | 7.00M | 4.45M | -661.00K | 3.85M | 13.25M | 9.36M |
| Net Cash Per Share | 5.41 | 5.29 | -2.21 | 31.42 | 169.78 | 174.48 |
| Filing Date Shares Outstanding | 1.95M | 1.14M | 721.91K | 198.09K | 126.39K | 74.19K |
| Total Common Shares Outstanding | 1.75M | 1.13M | 664.84K | 165.43K | 93.06K | 59.50K |
| Working Capital | -5.61M | -6.89M | -16.96M | -243.00K | 1.77M | 5.53M |
| Book Value Per Share | 10.62 | 25.03 | 33.44 | -1.38 | 19.25 | 93.36 |
| Tangible Book Value | -11.71M | -14.10M | -25.38M | -243.00K | 1.77M | 5.53M |
| Tangible Book Value Per Share | -6.69 | -12.46 | -38.18 | -1.47 | 19.06 | 92.97 |
| Machinery | 164.94K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -30.96M | -17.30M | -19.79M | -10.01M | -17.75M | -17.42M |
| Depreciation & Amortization | 14.00K | 4.00K | 4.00K | 4.13K | ||
| Asset Writedown & Restructuring Costs | 17.31M | 5.18M | ||||
| Stock-Based Compensation | 2.17M | 2.89M | 2.25M | 1.15M | 735.00K | 314.65K |
| Other Operating Activities | -378.00K | -936.00K | -1.56M | -6.71M | -5.32M | 242.50K |
| Change in Accounts Payable | 668.00K | -998.00K | 5.22M | -936.00K | -877.00K | -241.31K |
| Change in Other Net Operating Assets | 429.00K | 594.00K | 1.32M | 70.00K | 1.70M | -1.74M |
| Operating Cash Flow | -10.76M | -10.57M | -12.55M | -16.43M | -21.50M | -18.85M |
| Cash Acquisitions | 382.00K | |||||
| Investing Cash Flow | 382.00K | |||||
| Short-Term Debt Issued | 2.10M | 1.00M | ||||
| Total Debt Issued | 2.10M | 2.10M | 1.00M | |||
| Short-Term Debt Repaid | -1.05M | -1.85M | ||||
| Total Debt Repaid | -662.00K | -1.05M | -1.85M | |||
| Net Debt Issued (Repaid) | 1.44M | 1.05M | -855.00K | |||
| Issuance of Common Stock | 13.27M | 10.76M | 11.84M | 7.02M | 25.29M | 14.29M |
| Other Financing Activities | 1.04M | 1.37M | ||||
| Financing Cash Flow | 15.74M | 13.17M | 10.99M | 7.02M | 25.29M | 14.29M |
| Foreign Exchange Rate Adjustments | -3.00K | 1.00K | -4.00K | 7.00K | 105.00K | -140.73K |
| Net Cash Flow | 4.98M | 2.60M | -1.19M | -9.40M | 3.89M | -4.69M |
| Free Cash Flow | -10.76M | -10.57M | -12.55M | -16.43M | -21.50M | -18.85M |
| Free Cash Flow Per Share | -8.32 | -12.56 | -42.04 | -134.29 | -275.54 | -351.28 |
| Levered Free Cash Flow | -9.38M | -10.22M | 3.91M | -16.74M | -6.04M | -11.31M |
| Unlevered Free Cash Flow | -8.77M | -9.63M | 4.06M | -16.74M | -6.04M | -11.31M |
| Cash Interest Paid | 103.00K | 101.00K | 143.00K | |||
| Change in Working Capital | 1.10M | -404.00K | 6.54M | -866.00K | 822.00K | -1.98M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 18.83M | 13.23M | 32.30M | 17.64M | 34.98M | 71.40M |
| Enterprise Value | 11.83M | 12.86M | 31.05M | 10.46M | 26.83M | 58.00M |
| Last Close Price | 8.24 | 11.56 | 48.80 | 124.80 | 375.92 | 1,200.00 |
| PB Ratio | 0.78 | 0.47 | 1.45 | -77.02 | 19.53 | 12.85 |
| P/TBV Ratio | 19.72 | 12.91 | ||||
| Debt / Equity Ratio | 0.04 | 0.03 | 0.15 | |||
| Net Debt / Equity Ratio | -0.38 | -0.16 | 0.03 | 16.79 | -7.40 | -1.69 |
| Net Debt / EBITDA Ratio | 0.37 | -0.04 | 0.23 | 0.57 | 0.54 | |
| Net Debt / FCF Ratio | 0.65 | 0.42 | -0.05 | 0.23 | 0.62 | 0.50 |
| Quick Ratio | 0.55 | 0.42 | 0.13 | 0.84 | 1.10 | 1.54 |
| Current Ratio | 0.60 | 0.44 | 0.15 | 0.95 | 1.15 | 1.91 |
| Return on Equity (ROE) | -140.09% | -68.43% | -179.92% | -1,281.43% | -483.23% | -233.27% |
| Return on Assets (ROA) | -19.10% | -15.36% | -37.89% | -115.51% | -113.26% | -81.96% |
| Return on Capital Employed (ROCE) | -55.40% | -34.00% | -54.30% | 7,338.90% | -1,289.10% | -309.90% |
| Earnings Yield | -290.52% | -130.73% | -61.28% | -56.74% | -50.73% | -24.40% |
| FCF Yield | -57.14% | -79.87% | -38.87% | -93.17% | -61.47% | -26.40% |
| Buyback Yield / Dilution | -128.91% | -181.85% | -144.03% | -56.79% | -45.46% | -35.87% |